Ledger.Open graph →
SEC Form D · filed December 2, 2022

Nectar Life Sciences, Inc

Offering
$24.3M
Sold
$24.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark Lotke · New York, NYDirectorKen Chahine · New York, NYExec · DirectorPatrick Chun · New York, NYDirectorJames Joaquin · Emeryville, CADirectorKen Chahine · New York, NYExec · DirectorMark Lotke · New York, NYDirectorPatrick Chun · New York, NYDirectorJames Joaquin · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗